Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
BMC Pulm Med. 2022 May 2;22(1):175. doi: 10.1186/s12890-022-01970-8.
Although pulmonary rehabilitation is helpful for patients following lung cancer surgery, rehabilitation is not widely available, due in part to a lack of medical resources. Recent developments in digital health care have overcome the space limitations associated with in-person health care. This study will evaluate and compare the efficacy of three different smartphone healthcare systems in patients with lung cancer.
This single center randomized controlled study is designed to evaluate the efficacy of digital healthcare applications for lung cancer patients after thoracoscopic lung resection. A total of 320 patients will be enrolled and randomized 1:1:1:1 into four different groups, with one group each using the smartphone applications NOOM, Walkon, and Efilcare and the fourth being the control group without intervention. Questionnaires will be administered to patients at baseline and after 3, 6, and 12 months. The primary endpoint will be the score on the EuroQol five-dimension index. Secondary endpoints will include other questionnaires about quality of life and dyspnea.
This prospective randomized controlled study may allow assessments and comparisons of the efficacy of various smartphone applications in patients who undergo lung cancer surgery. This process may enable the introduction of healthcare interventions that maintain quality of life in patients with lung cancer. Trial registration CRIS, KCT0005447. Registered 06 October 2020, https://cris.nih.go.kr/cris/search/detailSearch.do/19346.
尽管肺康复对肺癌手术后的患者有帮助，但由于缺乏医疗资源，康复服务并不广泛。最近数字医疗保健的发展克服了与面对面医疗保健相关的空间限制。本研究将评估和比较三种不同的智能手机医疗保健系统在肺癌患者中的疗效。
这是一项单中心随机对照研究，旨在评估数字医疗应用程序对胸腔镜肺切除术后肺癌患者的疗效。将招募 320 名患者，并将其 1:1:1:1 随机分为四组，每组分别使用智能手机应用程序 NOOM、Walkon 和 Efilcare，第四组为无干预的对照组。将在基线和 3、6 和 12 个月后对患者进行问卷调查。主要终点是欧洲五维健康指数评分。次要终点将包括其他关于生活质量和呼吸困难的问卷。
这项前瞻性随机对照研究可以评估和比较各种智能手机应用程序在接受肺癌手术的患者中的疗效。这一过程可能使维持肺癌患者生活质量的医疗干预措施得以引入。试验注册 CRIS，KCT0005447。于 2020 年 10 月 6 日注册，https://cris.nih.go.kr/cris/search/detailSearch.do/19346。
